Septicemia caused by dysgonic fermenter 3 in a severely immunocompromised patient and isolation of the same microorganism from a stool specimen

Journal of Clinical Microbiology

Volumn 37, Issue 5, 1999, Pages 1617-1618

  Grob, René ^a,c   Zbinden, Reinhard ^a   Ruef, Christian ^a   Hackenthal, Matthias ^b   Diesterweg, Ingrid ^b   Altwegg, Martin ^a   Von Graevenitz, Alexander ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Krankenhaus Moabit   (Germany)

^c Labor Dr B Güntert   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN B; AMPICILLIN; ANTIINFECTIVE AGENT; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; CYTARABINE; DAUNORUBICIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; NETILMICIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TIOGUANINE; TOBRAMYCIN; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ANTIBIOTIC SENSITIVITY; APLASIA; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BLOOD CULTURE; CASE REPORT; DIARRHEA; DYSGONIC FERMENTER 3; FECES CULTURE; GRAM NEGATIVE BACTERIUM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RIBOTYPING; SEPTICEMIA;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 0032894748     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.5.1617-1618.1999     Document Type: Article

References (9)

1. Aronson, N. E., and C. J. Zbick. 1988. Dysgonic fermenter 3 bacteremia in a neutropenic patient with acute lymphocytic leukemia. J. Clin. Microbiol. 26: 2213-2215.
2. Blum, R. N., C. D. Berry, M. G. Phillips, D. L. Hamilos, and E. W. Koneman. 1992. Clinical illnesses associated with isolation of dysgonic fermenter 3 from stool samples. J. Clin. Microbiol. 30:396-400.
3. Martinetti, G., and M. Altwegg. 1990. rRNA gene restriction patterns and plasmid analysis as a tool for typing Salmonella enteritidis. Res. Microbiol. 141: 1151-1162.
4. Martínez-Sánchez, L., F. J. Vasallo, F. García-Garrote, L. Alcalá, M. Rodríguez-Créixems, and E. Bouza. 1998. Clinical isolation of a DF-3 microorganism and review of the literature. Clin. Microbiol. Infect. 4:344-346.
5. Onderdonk, A. B., and M. Sasser. 1995. Gas-liquid and high-performance liquid chromatographic methods for the identification of microorganisms, p. 123-129. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
6. Vandamme, P., M. Vancanneyt, A. van Belkum, P. Segers, W. G. V. Quint, K. Kersters, B. J. Paster, and F. E. Dewhirst. 1996. Polyphasic analysis of strains of the genus Capnocytophaga and Centers for Disease Control group DF-3. Int. J. Syst. Bacteriol. 46:782-791.
7. Van Steenbergen, T. J., U. van der Velden, F. Abbas, and J. de Graaff. 1991. Microflora and bacterial DNA restriction enzyme analysis in young adults with periodontitis. J. Periodontol. 62:235-241.
8. Wagner, D. K., J. J. Wright, A. F. Ansher, and V. J. Gill. 1988. Dysgonic fermenter 3-associated gastrointestinal disease in a patient with common variable hypogammaglobulinemia. Am. J. Med. 84:315-318.
9. Weyant, R. S., C. W. Moss, R. E. Weaver, D. G. Hollis, J. G. Jordan, E. C. Cook, and M. I. Daneshvar. 1996. Identification of unusual pathogenic gram-negative aerobic and facultatively anaerobic bacteria. Williams and Wilkins, Baltimore, Md.